Jeroen Eikenboom

MD, PhD, prof
Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
Leiden, Zuid-Holland, Netherlands

Presentation(s):

• OC 01.5 - People with mild hemophilia are at risk of joint disease: the nationwide cohort HiN-6 Study

  Saturday, June 22, 2024
  14:00 – 14:15 ICT

• PB0281 - Baseline coagulation factor levels determine desmopressin response in bleeding disorders: a systematic review and meta-analysis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0280 - Patient perspective of the burden and severity of von Willebrand disease

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0274 - Re-establishing von Willebrand Factor production in endothelial cells derived from von Willebrand Disease type 3 canine models through CRISPR-Cas9 mediated gene editing

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0342 - Silencing of the von Willebrand factor gene in pro-atherothrombotic APOE*3-Leiden.CETP transgenic mice

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0943 - Clinical characteristics and mortality of older patients diagnosed with acute pulmonary embolism on the emergency department, compared to other older patients in the emergency department

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0834 - Cross-reactivity of antiphospholipid antibodies with gut commensal proteins in antiphospholipid syndrome

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0897 - Targeted proteomics in antiphospholipid syndrome: a case-control study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0929 - Treatment of acute pulmonary embolism in older patients: focus on deviations from guideline recommendation for home treatment and reperfusion treatment

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 58.2 - Allele specific knock-out of mutant Von Willebrand factor in heterozygous Von Willebrand disease type 2A patient-derived ECFCs

  Tuesday, June 25, 2024
  09:45 – 10:00 ICT

• PB1373 - Time-dependent associations between COVID-19 disease severity, coagulation proteins, venous thromboembolism and all-cause mortality

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 61.2 - Determinants of successful immune tolerance induction in people with severe hemophilia A

  Tuesday, June 25, 2024
  15:00 – 15:15 ICT

• OC 63.3 - Specifications of ACMG/AMP Variant Curation Guidelines for VWF variants in type 2 von Willebrand disease: Recommendations by ClinGen’s von Willebrand Disease Variant Curation Expert Panel

  Tuesday, June 25, 2024
  15:15 – 15:30 ICT